Article Details
Retrieved on: 2022-08-04 15:21:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck's (NYSE: MRK) LYNPARZA as monotherapy or in combination with ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here